Sirt5 Attenuates Cisplatin-Induced Acute Kidney Injury through Regulation of Nrf2HO-1 and Bcl-2

الملخص EN

Cisplatin- (CDDP) induced acute kidney injury (AKI) limits the clinical use of cisplatin.

Several sirtuin (SIRT) family proteins are involved in AKI, while the roles of Sirt5 in cisplatin-induced AKI remain unknown.

In the present study, we characterized the role and mechanism of Sirt5 in cisplatin-induced apoptosis using the human kidney 2 (HK-2) cell line.

CDDP treatment decreased Sirt5 expression of HK-2 cells in a dose-dependent manner.

In addition, Sirt5 overexpression enhanced the metabolic activity in CDDP-treated HK-2 cells while Sirt5 siRNA attenuated it.

Forced expression of Sirt5 inhibited CDDP-induced apoptosis while Sirt5 siRNA showed the opposite effects.

Accordingly, Sirt5 overexpression inhibited the level of caspase 3 cleavage and cytochrome c levels.

Furthermore, we found that Sirt5 increased mitochondrial membrane potentials and ameliorated intracellular ROS production.

Mitotracker Red staining indicated that Sirt5 overexpression was able to maintain the mitochondrial density during CDDP treatment.

We also investigated possible downstream targets of Sirt5 and found that Sirt5 increased Nrf2, HO-1, and Bcl-2 while it decreased Bax protein expression.

Sirt5 siRNA showed the opposite effect on these proteins.

The levels of Nrf2, HO-1, and Bcl-2 proteins in HK-2 cells were also decreased after CDDP treatment.

Moreover, Nrf2 and Bcl-2 siRNA partly abolished the protecting effect of Sirt5 on CDDP-induced apoptosis and cytochrome c release.

Catalase inhibitor 3-AT also abolished the cytoprotective effect of Sirt5.

Together, the results demonstrated that Sirt5 attenuated cisplatin-induced apoptosis and mitochondrial injury in human kidney HK-2 cells, possibly through the regulation of Nrf2/HO-1 and Bcl-2.